Effects of Restylane-L® Filler Injection for Non-Surgical Rhinoplasty

• Status: Completed
• Trial end date: 2020-07-21
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this research is to determine the effects of Restylane-L® Filler Injection for Non-Surgical Rhinoplasty on First Impressions and Quality of Life determined by using the FACE-Q Scale.

Secondary objectives include:

To determine the efficacy of Restylane-L® Filler injection to the nose in reduction of convexity of the nasal dorsum as measured on pre/post injection 2D photographs.

To measure changes in nasal projection and rotation after injection with Restylane-L® Filler in subset of patients who underwent nasal tip augmentation.

To determine the safety of Restylane-L® Filler injection to the nose for non-surgical rhinoplasty.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: DeNova Research
• Collaborators: Galderma; Galderma R&D
• Treatments: Hyaluronic Acid

Criteria

Inclusion Criteria:

1. Males and females of ages 21 and above.

2. Subjects will be required not to have had previous filler injections, or other cosmetic treatments to the nose within the last 12 months.

3. Subjects that understand the purpose and aspects of the study, freely sign the consent and complete the required treatment and follow up visit.

Exclusion Criteria:

1. Males and females below age of 21.

2. Subjects who have had previous filler injections, or other cosmetic treatments to the nose within the last 12 months.

3. Subjects who are pregnant or nursing.

4. Subjects with a known allergy or sensitivity to any component of the study ingredients.

5. Any history of bleeding disorders (iatrogenic or otherwise). This includes persons who have undergone therapy with thrombolytics, anticoagulants, or inhibitors of platelet aggregation in the preceding 3 weeks.

6. Anyone taking aspirin, ibuprofen, St. John's Wort, or high doses of Vitamin E supplements in the last 3 weeks.

7. Subjects with diseases, injuries, or disabilities of the nose, including those with autoimmune disease affecting the nose, implants, and previous surgical rhinoplasty.

8. Subjects that do not understand the purpose and aspects of the study, do not sign the consent and do not complete the required treatment and follow up visit will also be excluded.